Understanding common side effects
CYRAMZA in combination with docetaxel (a type of chemotherapy) may cause side effects. If you experience new symptoms while on treatment, it is important that you speak with your doctor.
Explore the most common side effects of CYRAMZA, below.
The most common side effects were:
Low white blood cell count, tiredness, mouth sores and swelling in the lining of the mouth, nosebleeds, low white blood cell count with fever, swelling in the arms, legs, hands, or feet, low platelet count, increased production of tears, and high blood pressure.
The most common serious side effects were:
Low white blood cell count with fever, pneumonia, and low white blood cell count – Medication to increase white blood cell count was given to 42% of CYRAMZA plus docetaxel-treated patients and 37% of patients who received placebo plus docetaxel.
Please see Important Safety Information, including Boxed Warning for severe bleeding, tears in stomach or bowel wall, and difficulty in wound healing, below, and full Prescribing Information for complete safety information for CYRAMZA.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/safety/medwatch or call 1-800-FDA-1088.
Talk to your doctor about any questions, concerns, or side effects you might have with CYRAMZA. Your doctor may be able to make recommendations to help you feel more comfortable.